Stay updated on Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page.

Latest updates to the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe update adds a new site revision label (v3.4.2) and removes the previous funding-status notice and earlier revision tag (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedThe page now displays a government funding notice about NIH operations and an updated site revision to v3.4.1, with the prior v3.4.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedMinor UI/content updates: a Show glossary option was added; labels such as 'Last Update Submitted that Met QC Criteria' (capitalization) and 'No FEAR Act Data' were updated, and the revision number changed to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page header now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter now displays Revision: v3.3.3. The HHS Vulnerability Disclosure link and Revision: v3.3.2 have been removed.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2; no study content or functionality appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page.